Alcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
Follow ALC
Alert me
Alcon (ALC) Current ratio
Alcon's current ratio at the end of the quarter to 30 June 2026 was 2.1×, down 0.0× from fiscal 2025 (2.1×). Over the past ten years it has ranged from 1.8× (fiscal 2018) to 2.8× (fiscal 2024); the current reading is higher than 60% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 2.1× | (23.63%) |
| FY2024 | 2.8× | 17.61% |
| FY2023 | 2.4× | 24.16% |
| FY2022 | 1.9× | (12.95%) |
| FY2021 | 2.2× | (1.35%) |
| FY2020 | 2.2× | 19.92% |
| FY2019 | 1.8× | 2.57% |
| FY2018 | 1.8× | (2.85%) |
| FY2017 | 1.8× | 1.93% |
| FY2016 | 1.8× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 2.1× | (5.09%) |
| Mar 2026 | 2.2× | 4.19% |
| Dec 2025 | 2.1× | (0.14%) |
| Sep 2025 | 2.1× | (18.58%) |
| 26 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| MDLN Medline Inc. compare | 4.0× |
| WST West Pharmaceutical Services, Inc. compare | 2.8× |
| RMD ResMed Inc. compare | 2.6× |
| ALC Alcon | 2.1× |
| BAX Baxter International Inc. compare | 1.8× |
| ALGN Align Technology, Inc. compare | 1.4× |
| COO The Cooper Companies, Inc. compare | 1.2× |
| SOLV Solventum Corporation compare | 1.0× |
| BDX Becton, Dickinson and Company compare | 0.9× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on ALC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement